Skip to content

Kyaterekera Project: A Combination Intervention Addressing Sexual Risk-Taking Behaviors Among Vulnerable Women in Uganda

Kyaterekera Project: A Combination Intervention Addressing Sexual Risk-Taking Behaviors Among Vulnerable Women in Uganda

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03583541
Enrollment
542
Registered
2018-07-11
Start date
2019-08-01
Completion date
2023-08-23
Last updated
2025-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Control arm_Bolstered Care, Treatment arm_HIVRR+S+FL, Treatment arm_HIVRR+S+FL+M

Keywords

Vulnerable women, Female sex workers, Combination interventions, Economic empowerment, HIV/AIDS, Sexually transmitted infections, Sub-Saharan Africa, Uganda

Brief summary

Guided by Social Cognitive and Asset theories as well as Behavioral Economics (BE) principles,the proposed RCT is carefully designed to test the additive contributions of savings-led microfinance beyond traditional HIV risk reduction (HIVRR) alone in decreasing biologically confirmed STIs, including HIV, improving high risk behavioral outcomes, while concurrently reducing income from sex work. Working within established health care- and outreach-based settings, we will randomly assign 990 FSWs to one of three study arms (11 town centers each): (1) a control arm comprising treatment as usual (TAU) for FSWs (quarterly 2-3 hour health education sessions, HIV testing services, and STI screening), bolstered with 4 evidence-based sessions of HIVRR provided by local providers (n=330 ); or (2) a treatment arm including TAU, 4 sessions of HIVRR, combined with receipt of a matched savings account (HIVRR+S) to be used on short-term and/or long term consumption and skills development per a participant's discretion/choice (n=330); or (3) a treatment arm including TAU, 4 sessions of HIVRR, combined with a matched savings account for short-term and/or long term consumption and skills development, plus 6 sessions of financial literacy with integrated BE principles (e.g., delay discounting, economic utility, information salience, and loss aversion), and 8 mentoring sessions for supportive transition to options for alternative income (HIVRR+S+FLM) (n=330).\* \*Revision note: Following COVID-19, with approval from NIMH (on record if requested), the HIVRR+S+FLM treatment of the study has been combined with the HIVRR+S+FL treatment arm. The total sample size has been revised to 542 participants, with approval from NIMH. Moreover, biomarker data collection at 6 and 12 months were suspended due to COVID-19.

Detailed description

Female Sex Workers (FSWs) in sub-Saharan Africa (SSA) have been identified as a high-risk group for the spread of HIV/AIDS, with those in poor areas and HIV hotspots being especially vulnerable. Research has shown that the primary reason poor women engage in commercial sex work is financial instability. Given these challenges, poor women require support over and above HIV prevention education. We propose to test the impact of adding economic empowerment (EE) components to traditional HIV risk reduction (HIVRR) to reduce new incidence of sexually transmitted infections (STIs) and of HIV among FSWs in Rakai and Masaka districts in Uganda. Guided by social-cognitive and asset theories, the study provides an avenue for FSWs to explore alternative means of safe and sustainable income to replace sex work. The study is informed by a previously tested microfinance (MF) intervention for FSWs in Mongolia, a pilot study conducted with FSWs in Masaka and Rakai, surveillance studies by RHSP, and EE interventions among AIDS-affected families in Uganda. Using a cluster-design we will randomly assign 990 FSWs from 33 matched town centers to one of three study arms (11 town centers in each condition): (1) A control arm comprising of treatment as usual (TAU) for FSWs in the study area bolstered with 4 evidence-based sessions of HIVRR provided by local providers (n=330); or (2) A treatment arm including TAU, 4 sessions of HIVRR, combined with receipt of a matched savings account (HIVRR+S+FL) to be used on short- and/or long-term consumption and skills development as per participants' own discretion plus 6 sessions of financial literacy (n=330); or (3) A treatment arm including TAU, 4 sessions of HIVRR, combined with a matched savings account to be used on short-term and/or long term consumption and skills development as per a participant's own discretion plus 6 sessions of financial literacy and 8 mentoring sessions for supportive transition to alternative income options (HIVRR+S+FLM) (n=330).\* This RCT study's aims are to: Aim1: Examine the impact of a financial savings-led MF intervention using HIVRR+S+FL and HIVRR+S+FLM on HIV biological and behavioral outcomes in FSWs (Primary outcomes: women's cumulative incidence of biologically confirmed STIs and reported number and proportion of unprotected sexual acts with regular and paying partners; Secondary outcomes: women's rate of new HIV cases, proportion of monthly income from sex and nonsex work, reported number and proportion on preventive behaviors, and for HIV+ women only, viral load as a marker of ART adherence). Aim 2: Examine intervention mediation and effect modification to assess whether primary outcomes are mediated/moderated by participant characteristics; whether key theory-driven variables and Behavioral Economics measures mediate/moderate intervention outcomes. Aim 3: Qualitatively and quantitatively examine implementation in each study condition; Aim 4: Assess the cost and cost-effectiveness of the HIVRR+S+FL and HIVRR+S+FLM intervention compared with traditional HIVRR in terms of cumulative number of STI and HIV cases averted over the 24-month period. \*Revision note: Following COVID-19, with approval from NIMH (on record if requested), the HIVRR+S+FLM treatment of the study has been combined with the HIVRR+S+FL treatment arm. The total sample size has been revised to 542 participants, with approval from NIMH. Moreover, biomarker data collection at 6 and 12 months were suspended due to COVID-19.

Interventions

BEHAVIORALHIV Risk Reduction

This is an intervention comprised of 4 sessions provided twice per week for 2 weeks of an evidence-based, HIV/STI risk reduction intervention.

This evidence-based Financial Education Core Curriculum addresses the importance of savings, banking services, budgeting debt management. Undarga adaptation for FSWs included shortening and simplifying sessions while retaining core elements; adding weekly check-ins due to safety concerns FSWs share related to intervention participation, and safety planning as needed. We will further adapt sessions in months 1-6 to assure language and illustrative examples are culturally consonant, and to infuse BE principles consistent with HIVRR. During sessions 1 & 2 we will include information on delay discounting, for example, learning to understand the tendency to prefer small immediate rewards over larger available at a later time; sessions 3 & 4 will include details on economic utility; sessions 5 will contain information on salience (e.g. understanding occasions when women may minimize triggers to unsafe sex); and session 6 will address loss aversion.

BEHAVIORALMentorship

Mentorship. Mentorship to bridge the transition from FL and savings to a vocational change is a critical component of this intervention. These sessions are intended to support the transition -equipped with financial literacy and savings -to vocational, educational, employment or small business development training using matched savings. The mentorship sessions are adapted from the pilot study and integrate components (e.g., referral and linkage, coaching, exchange visits to model farmers) from income-generating activities provided by our collaborating partner, RTY. All sessions include check-in and individual attention. The first 4 sessions focus on identifying options for vocational, educational, employment or business development training. The second 4 sessions include invited experts in identified areas of interest by group members for more intensive time and attention to individualized needs to make the transition.

BEHAVIORALMatched savings individual development account

A matched savings individual development account (hereafter IDA) is a savings account held at a local bank whereby deposits made by the woman are matched by the intervention to encourage savings and investment in skills and asset development. The accounts introduce women to financial management skills, introduce them to formal financial institutions, and by matching their deposits, incentivize women to save small amounts. Each woman will receive an IDA held in her own name. Women will be allowed and indeed encouraged to contribute up to 50,000 shillings (\ 15 USD) per month towards their IDAs. The maximum amount of women's contribution to be matched will be an equivalent of US$15 per month for 10 months. During the intervention, monthly account statements will be generated for women to note their accumulated savings. During the intervention, women will have direct access to both their personal savings deposited in the accounts and the match provided by the study.

Sponsors

Columbia University
CollaboratorOTHER
Indiana University
CollaboratorOTHER
Rakai Health Sciences Program
CollaboratorOTHER
Reach the Youth Uganda
CollaboratorOTHER
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. at least 18 years old 2. report having engaged in vaginal or anal intercourse in the past 90 days in exchange for money, alcohol, or other goods 3. report at least one episode of unprotected sexual intercourse in the past 90 days with either a paying, casual, or regular sexual partner.

Exclusion criteria

1. have a cognitive or severe psychiatric impairment that would prevent comprehension of study procedures as assessed during Informed Consent process 2. are unwilling or unable to commit to completing the study 3. have previously been randomized.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With STIs24 monthsNumber of participants testing positive for any of the three STI including Gonorrhea, Trichomonas or Chlamydia, as assessed using biomarkers
Number of Unprotected Sexual Acts With a Regular Partner24 monthsNumber of unprotected sexual acts (e.g. vaginal and anal sexual acts) with a regular partner
Number of Unprotected Sexual Acts With a Paying Partner24 monthsNumber of unprotected sexual acts (e.g. vaginal and anal sexual acts) with a paying partner

Secondary

MeasureTime frameDescription
Preventive Behaviors/Condom Use With a Paying Partner24 monthsPreventive behaviors was assessed by number of times a participant used condoms with a paying partner during sexual acts.
Number of Participants With HIV24 monthsNumber of participants testing positive for HIV, assessed using biomarker data.
Preventive Behaviors/Condom Use With a Regular Partner24 monthsPreventive behaviors was assessed by number of times a participant used condoms with a regular partner during sexual acts.
Viral Suppression24 monthsViral Suppression for women living with HIV was assessed using detectable vs undetectable viral load.
Proportion of Income From Sex Work24 monthsParticipants reported their average total income and proportion of income from sex work. Proportion of income from sex work was calculated as average monthly total income as the denominator and income from sex work as the numerator.

Countries

Uganda

Participant flow

Pre-assignment details

Following COVID-19, with approval from NIMH (on record if requested), the HIVRR+S+FLM treatment arm of the study has been combined with the HIVRR+S+FL treatment arm. The total sample size has been revised to 542 participants, with approval from NIMH.

Participants by arm

ArmCount
Control Arm: Bolstered Treatment
Women in the control condition (and in the treatment arms) will receive treatment as usual (TAU) which includes: health education, HIV testing services, STI screening and treatment in a session that lasts about 2 hours, provided on a quarterly basis. This will be bolstered with 4 sessions of an evidence-based, HIV/STI risk reduction (HIVRR) intervention
186
Treatment Arm: HIVRR+S+FL
Women in this arm will receive TAU for FSW and the 4 HIVRR sessions, and two additional intervention components: 1) Financial Literacy: This evidence-based Financial Education Core Curriculum addresses the importance of savings, banking services, budgeting debt management; and 2) Matched savings individual development account.The accounts introduce women to financial management skills, introduce them to formal financial institutions, and by matching their deposits, incentivize women to save small amounts. Each woman will receive an IDA held in her own name. Women will be allowed and indeed encouraged to contribute up to 50,000 shillings (\ 15 USD) per month towards their IDAs. The maximum amount of women's contribution to be matched will be an equivalent of US$15 per month for 10 months. During the intervention, monthly account statements will be generated for women to note their accumulated savings. During the intervention, women will have direct access to both their personal savings deposited in the accounts and the match provided by the study.
356
Total542

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up3165

Baseline characteristics

CharacteristicTotalControl Arm: Bolstered TreatmentTreatment Arm: HIVRR+S+FL
Age, Continuous31.4 years
STANDARD_DEVIATION 7.18
31.2 years
STANDARD_DEVIATION 7.18
31.4 years
STANDARD_DEVIATION 7.39
Number of Participants with HIV220 participants79 participants141 participants
Number of Participants with STIs57 participants24 participants33 participants
Number of Unprotected Sexual Acts with a Paying Partner2.64 unprotected sexual acts
STANDARD_DEVIATION 9.98
3.09 unprotected sexual acts
STANDARD_DEVIATION 11.83
2.41 unprotected sexual acts
STANDARD_DEVIATION 8.86
Number of Unprotected Sexual Acts with a Regular Partner4.33 unprotected sexual acts
STANDARD_DEVIATION 9.26
3.96 unprotected sexual acts
STANDARD_DEVIATION 8.96
4.52 unprotected sexual acts
STANDARD_DEVIATION 9.41
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
542 Participants186 Participants356 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
Uganda
542 participants186 participants356 participants
Sex: Female, Male
Female
542 Participants186 Participants356 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1860 / 356
other
Total, other adverse events
0 / 1860 / 356
serious
Total, serious adverse events
0 / 1860 / 356

Outcome results

Primary

Number of Participants With STIs

Number of participants testing positive for any of the three STI including Gonorrhea, Trichomonas or Chlamydia, as assessed using biomarkers

Time frame: 24 months

Population: Due to missing data, the number of participants analyzed reduced to 411 (35 participants missing STI data).

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Control Arm: Bolstered TreatmentNumber of Participants With STIs17 Participants
Treatment Arm: HIVRR+S+FLNumber of Participants With STIs39 Participants
Primary

Number of Unprotected Sexual Acts With a Paying Partner

Number of unprotected sexual acts (e.g. vaginal and anal sexual acts) with a paying partner

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Control Arm: Bolstered TreatmentNumber of Unprotected Sexual Acts With a Paying Partner0.45 unprotected sexual actsStandard Deviation 1.23
Treatment Arm: HIVRR+S+FLNumber of Unprotected Sexual Acts With a Paying Partner0.62 unprotected sexual actsStandard Deviation 1.87
Primary

Number of Unprotected Sexual Acts With a Regular Partner

Number of unprotected sexual acts (e.g. vaginal and anal sexual acts) with a regular partner

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Control Arm: Bolstered TreatmentNumber of Unprotected Sexual Acts With a Regular Partner5.16 unprotected sexual actsStandard Deviation 8.25
Treatment Arm: HIVRR+S+FLNumber of Unprotected Sexual Acts With a Regular Partner4.39 unprotected sexual actsStandard Deviation 8.52
Secondary

Number of Participants With HIV

Number of participants testing positive for HIV, assessed using biomarker data.

Time frame: 24 months

Population: Only participants who tested HIV negative as 18 months follow-up assessments were retested.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Control Arm: Bolstered TreatmentNumber of Participants With HIV65 Participants
Treatment Arm: HIVRR+S+FLNumber of Participants With HIV117 Participants
Secondary

Preventive Behaviors/Condom Use With a Paying Partner

Preventive behaviors was assessed by number of times a participant used condoms with a paying partner during sexual acts.

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Control Arm: Bolstered TreatmentPreventive Behaviors/Condom Use With a Paying Partner2.12 preventive behaviorsStandard Deviation 2.99
Treatment Arm: HIVRR+S+FLPreventive Behaviors/Condom Use With a Paying Partner1.89 preventive behaviorsStandard Deviation 2.51
Secondary

Preventive Behaviors/Condom Use With a Regular Partner

Preventive behaviors was assessed by number of times a participant used condoms with a regular partner during sexual acts.

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Control Arm: Bolstered TreatmentPreventive Behaviors/Condom Use With a Regular Partner0.41 preventive behaviorsStandard Deviation 2.15
Treatment Arm: HIVRR+S+FLPreventive Behaviors/Condom Use With a Regular Partner0.34 preventive behaviorsStandard Deviation 1.53
Secondary

Proportion of Income From Sex Work

Participants reported their average total income and proportion of income from sex work. Proportion of income from sex work was calculated as average monthly total income as the denominator and income from sex work as the numerator.

Time frame: 24 months

ArmMeasureValue (MEDIAN)
Control Arm: Bolstered TreatmentProportion of Income From Sex Work0.57 proportion of income
Treatment Arm: HIVRR+S+FLProportion of Income From Sex Work0.58 proportion of income
Secondary

Viral Suppression

Viral Suppression for women living with HIV was assessed using detectable vs undetectable viral load.

Time frame: 24 months

Population: Viral suppression was only assessed from participants who tested positive for HIV at 24-months follow-up.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Control Arm: Bolstered TreatmentViral Suppression50 Participants
Treatment Arm: HIVRR+S+FLViral Suppression91 Participants

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026